{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:25:09Z","timestamp":1775694309591,"version":"3.50.1"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"31","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,8,1]]},"abstract":"<jats:p>Accurate assessment of renal function is critical for early detection and management of chronic kidney disease (CKD). While estimated glomerular filtration rate (eGFR) remains the gold standard for evaluating renal filtration capacity, its limitations in identifying early metabolic-driven dysfunction necessitate complementary biomarkers. The cardiometabolic index (CMI), reflects metabolic dysregulation but its link to eGFR-defined renal impairment remains unstudied. In this cross-sectional analysis of 13,696 U.S. adults (National Health and Nutrition Examination Survey 1999\u20132018), eGFR was calculated using the 2021 CKD Epidemiology Collaboration (CKD-EPI) creatinine equation (eGFR\u2005&lt;\u200560 mL\/min\/1.73m\u00b2 indicating reduced renal function). CMI, integrating triglyceride-to- high-density-lipoprotein cholesterol ratio (TG\/HDL-C) and waist-to-height ratio (WHtR). Weighted multivariable logistic regression models adjusted for sociodemographic, lifestyle, and clinical covariates assessed CMI-eGFR associations. Restricted cubic spline and threshold analyses explored nonlinear relationships, while subgroup analyses tested consistency across populations. Higher CMI quintiles showed a dose-dependent increase in reduced eGFR prevalence (Q1: 5.3% vs Q5: 23.8%, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.001). Fully adjusted models revealed 2.16-fold elevated odds of reduced eGFR in the highest CMI quintile (95% confidence interval (CI): 1.27\u20133.69) versus the lowest. Restricted cubic spline analysis identified a nonlinear threshold effect at CMI\u2005=\u20050.182: below this threshold, each 1-unit CMI increase raised eGFR risk by 86% (95% CI = 1.49\u20132.23; <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.045), while above it, risk increased by 33% (95% CI = 1.11\u20131.59; <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.002). Subgroup analyses confirmed consistent associations in females, nondiabetics, and older adults (all <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.05), with no significant interactions. Elevated CMI independently predicts reduced renal function, underscoring its utility as a metabolic biomarker for early CKD detection. The identified threshold (CMI\u2005\u2265\u20050.182) highlights a critical inflection point for clinical risk stratification, advocating CMI integration into routine screening to guide preventive strategies against metabolic-driven renal impairment.<\/jats:p>","DOI":"10.1097\/md.0000000000043653","type":"journal-article","created":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T23:01:52Z","timestamp":1754089312000},"page":"e43653","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Cardiometabolic index is associated with impaired renal function: Nonlinear threshold effects and dose\u2013response relationships in a national cohort (NHANES 1999\u20132018)"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-7903-9743","authenticated-orcid":false,"given":"Zhengyang","family":"Zhu","sequence":"first","affiliation":[{"name":"Department of Postgraduate, First Clinical Medical College, Anhui University of Chinese Medicine, Hefei, Anhui Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kejun","family":"Ren","sequence":"additional","affiliation":[{"name":"Department of Nephrology, First Affiliated Hospital, Anhui University of Chinese Medicine, Hefei, Anhui Province, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaowei","family":"Duan","sequence":"additional","affiliation":[{"name":"Department of Nephrology, First Affiliated Hospital, Anhui University of Chinese Medicine, Hefei, Anhui Province, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xulei","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Nephrology, First Affiliated Hospital, Anhui University of Chinese Medicine, Hefei, Anhui Province, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Lv","sequence":"additional","affiliation":[{"name":"Department of Nephrology, First Affiliated Hospital, Anhui University of Chinese Medicine, Hefei, Anhui Province, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Nephrology, First Affiliated Hospital, Anhui University of Chinese Medicine, Hefei, Anhui Province, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of Nephrology, First Affiliated Hospital, Anhui University of Chinese Medicine, Hefei, Anhui Province, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Nephrology, First Affiliated Hospital, Anhui University of Chinese Medicine, Hefei, Anhui Province, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250918","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","article-title":"Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.","volume":"395","year":"2020","journal-title":"Lancet (London, England)"},{"key":"R2-20250918","doi-asserted-by":"crossref","first-page":"825","DOI":"10.7326\/0003-4819-158-11-201306040-00007","article-title":"Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline.","volume":"158","author":"Stevens","year":"2013","journal-title":"Ann Intern Med"},{"key":"R3-20250918","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1016\/S0140-6736(14)61601-9","article-title":"Worldwide access to treatment for end-stage kidney disease: a systematic review.","volume":"385","author":"Liyanage","year":"2015","journal-title":"Lancet (London, England)"},{"key":"R4-20250918","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1159\/000443450","article-title":"Early biomarkers of renal damage in relation to arterial stiffness and inflammation in male coronary artery disease patients.","volume":"41","author":"Paapstel","year":"2016","journal-title":"Kidney Blood Pressure Res"},{"key":"R5-20250918","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.trsl.2016.12.004","article-title":"The metabolic syndrome and chronic kidney disease.","volume":"183","author":"Zhang","year":"2017","journal-title":"Transl Res"},{"key":"R6-20250918","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2147\/DMSO.S231656","article-title":"Visceral adiposity index and chronic kidney disease in a non-diabetic population: a cross-sectional study.","volume":"13","author":"Xiao","year":"2020","journal-title":"Diabetes Metab Syndr Obes"},{"key":"R7-20250918","doi-asserted-by":"crossref","first-page":"340","DOI":"10.15446\/rsap.v20n3.61259","article-title":"Indice cardiometab\u00f3lico como predictor de factores de riesgo cardiovascular en adolescentes.","volume":"20","author":"Acosta-Garc\u00eda","year":"2018","journal-title":"Rev Salud Publica (Bogota)"},{"key":"R8-20250918","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.3390\/jcm12093055","article-title":"Cardiometabolic index (CMI) and visceral adiposity index (VAI) highlight a higher risk of metabolic syndrome in women with severe obesity.","volume":"12","author":"Lazzer","year":"2023","journal-title":"J Clin Med"},{"key":"R9-20250918","doi-asserted-by":"crossref","first-page":"114465","DOI":"10.1016\/j.biopha.2023.114465","article-title":"The role of lipotoxicity in kidney disease: from molecular mechanisms to therapeutic prospects.","volume":"161","author":"Ren","year":"2023","journal-title":"Biomed Pharmacother = Biomedecine & pharmacotherapie"},{"key":"R10-20250918","doi-asserted-by":"crossref","first-page":"691369","DOI":"10.1155\/2012\/691369","article-title":"Insulin resistance in patients with chronic kidney disease.","volume":"2012","author":"Liao","year":"2012","journal-title":"J Biomed Biotechnol"},{"key":"R11-20250918","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1089\/met.2023.0161","article-title":"Effects of metabolic syndrome and its components on chronic kidney disease and renal function: a two-sample mendelian randomization study.","volume":"22","author":"Yang","year":"2024","journal-title":"Metab Syndrome Related Disord"},{"key":"R12-20250918","doi-asserted-by":"crossref","first-page":"e00023","DOI":"10.1097\/IN9.0000000000000023","article-title":"Adipose tissue metabolic changes in chronic kidney disease.","volume":"5","author":"Serrano","year":"2023","journal-title":"Immunometabolism"},{"key":"R13-20250918","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000350726","article-title":"Oxidative stress and cell senescence combine to cause maximal renal tubular epithelial cell dysfunction and loss in an in vitro model of kidney disease.","volume":"122","author":"Small","year":"2012","journal-title":"Nephron Exp Nephrol"},{"key":"R14-20250918","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.athplu.2023.04.001","article-title":"HDL and chronic kidney disease.","volume":"52","author":"Pavanello","year":"2023","journal-title":"Atherosclerosis plus"},{"key":"R15-20250918","doi-asserted-by":"crossref","first-page":"e76632","DOI":"10.1371\/journal.pone.0076632","article-title":"Validity of U.S. nutritional surveillance: National Health and Nutrition Examination Survey caloric energy intake data, 1971-2010.","volume":"8","author":"Archer","year":"2013","journal-title":"PLoS One"},{"issue":"4 Suppl","key":"R16-20250918","doi-asserted-by":"crossref","first-page":"1203S","DOI":"10.1093\/ajcn\/65.4.1203S","article-title":"Dietary methods research in the third National Health and Nutrition Examination Survey: underreporting of energy intake.","volume":"65","author":"Briefel","year":"1997","journal-title":"Am J Clin Nutr"},{"key":"R17-20250918","doi-asserted-by":"crossref","first-page":"1004855","DOI":"10.3389\/fendo.2022.1004855","article-title":"Cardiometabolic index: a new predictor for metabolic associated fatty liver disease in Chinese adults.","volume":"13","author":"Duan","year":"2022","journal-title":"Front Endocrinol"},{"key":"R18-20250918","doi-asserted-by":"crossref","first-page":"324","DOI":"10.14789\/jmj.JMJ24-0019-P","article-title":"Global standardization of lipid\/lipoprotein testing.","volume":"70","author":"Miida","year":"2024","journal-title":"Juntendo Iji zasshi = Juntendo Med J"},{"key":"R19-20250918","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","article-title":"New creatinine- and cystatin C-based equations to estimate GFR without race.","volume":"385","author":"Inker","year":"2021","journal-title":"N Engl J Med"},{"key":"R20-20250918","first-page":"1","article-title":"National Health and Nutrition Examination Survey: estimation procedures, 2007-2010.","volume":"2","author":"Curtin","year":"2013","journal-title":"Vital Health Stat Series 2"},{"key":"R21-20250918","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12874-024-02454-5","article-title":"The proper application of logistic regression model in complex survey data: a systematic review.","volume":"25","author":"Dey","year":"2025","journal-title":"BMC Med Res Methodol"},{"key":"R22-20250918","doi-asserted-by":"crossref","first-page":"e0318736","DOI":"10.1371\/journal.pone.0318736","article-title":"Association between cardiometabolic index and albuminuria: evidence from NHANES 2017-2020.","volume":"20","author":"Xu","year":"2025","journal-title":"PLoS One"},{"key":"R23-20250918","doi-asserted-by":"crossref","first-page":"1485477","DOI":"10.3389\/fendo.2025.1485477","article-title":"Associations between cardiometabolic index with kidney stones: evidence from NHANES 2007-2018.","volume":"16","author":"Zhong","year":"2025","journal-title":"Front Endocrinol"},{"key":"R24-20250918","doi-asserted-by":"crossref","first-page":"1507035","DOI":"10.3389\/fnagi.2024.1507035","article-title":"Association between cardiometabolic index and biological aging in the US population: evidence from NHANES 2015-2020.","volume":"16","author":"Sun","year":"2024","journal-title":"Front Aging Neurosci"},{"key":"R25-20250918","doi-asserted-by":"crossref","first-page":"1582495","DOI":"10.3389\/fnut.2025.1582495","article-title":"Association between uric acid to high-density lipoprotein cholesterol ratio and chronic kidney disease in Chinese patients with type 2 diabetes mellitus: a cross-sectional study.","volume":"12","author":"Chen","year":"2025","journal-title":"Front Nutr"},{"key":"R26-20250918","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1111\/j.1523-1755.2005.09916.x","article-title":"Dyslipidemia and the progression of renal disease in chronic renal failure patients.","author":"Cases","year":"2005","journal-title":"Kidney Int"},{"key":"R27-20250918","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2165\/00129784-200404040-00004","article-title":"Dyslipidemia in visceral obesity: mechanisms, implications, and therapy.","volume":"4","author":"Chan","year":"2004","journal-title":"Am J Cardiovasc Drugs"},{"key":"R28-20250918","doi-asserted-by":"crossref","first-page":"12724","DOI":"10.1038\/srep12724","article-title":"FFA-ROS-P53-mediated mitochondrial apoptosis contributes to reduction of osteoblastogenesis and bone mass in type 2 diabetes mellitus.","volume":"5","author":"Li","year":"2015","journal-title":"Sci Rep"},{"key":"R29-20250918","doi-asserted-by":"crossref","first-page":"805281","DOI":"10.3389\/fphar.2022.805281","article-title":"Fatty Acid \u03b2-Oxidation in kidney diseases: perspectives on pathophysiological mechanisms and therapeutic opportunities.","volume":"13","author":"Gao","year":"2022","journal-title":"Front Pharmacol"},{"key":"R30-20250918","first-page":"69","article-title":"Adipokines and their role in chronic kidney disease.","volume":"5","author":"Khazaei","year":"2015","journal-title":"J Nephropharmacol"},{"key":"R31-20250918","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1111\/1440-1681.13556","article-title":"Renal lipotoxicity: insights from experimental models.","volume":"48","author":"Castro","year":"2021","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"R32-20250918","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12902-024-01822-y","article-title":"Threshold-effect of ferritin levels with pathoglycemia in Chinese adults: a cross-sectional study based on China health and nutrition survey data.","volume":"25","author":"Yang","year":"2025","journal-title":"BMC Endocr Disord"},{"key":"R33-20250918","doi-asserted-by":"crossref","first-page":"755","DOI":"10.34067\/KID.0006152020","article-title":"Podocyte lipotoxicity in CKD.","volume":"2","author":"Kim","year":"2021","journal-title":"Kidney360"},{"key":"R34-20250918","doi-asserted-by":"crossref","first-page":"102830","DOI":"10.1016\/j.pmedr.2024.102830","article-title":"Nonlinear associations between dietary zinc intake and cardiovascular disease risk, a National cross-sectional study based on the NHANES 2005-2018.","volume":"45","author":"Zhang","year":"2024","journal-title":"Prev Med Rep"},{"key":"R35-20250918","doi-asserted-by":"crossref","first-page":"108389","DOI":"10.1016\/j.jdiacomp.2022.108389","article-title":"Early intervention and intensive management of patients with diabetes, cardiorenal, and metabolic diseases.","volume":"37","author":"Handelsman","year":"2023","journal-title":"J Diabetes Complications"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000043653","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T22:01:37Z","timestamp":1758232897000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000043653"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,1]]},"references-count":35,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000043653","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,1]]},"assertion":[{"value":"2025-05-19","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-11","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}